We are live on ! Find out more
BLFS icon

BioLife Solutions

80 hedge funds and large institutions have $170M invested in BioLife Solutions in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

33% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 21

13% more capital invested

Capital invested by funds: $150M → $170M (+$19.9M)

10% more funds holding

Funds holding: 7380 (+7)

2.59% more ownership

Funds ownership: 47.77%50.36% (+2.6%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $441K

Holders
80
Holders Change
+7
Holders Change %
+9.59%
% of All Funds
1.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
28
Reduced
21
Closed
4
Calls
Puts
$441K
Net Calls
-$441K
Net Calls Change
-$441K
Name Holding Trade Value Shares
Change
Change in
Stake
CC
1
Casdin Capital
New York
$40.4M
PWAM
2
Park West Asset Management
California
$13.1M +$8.36M +445,511 +129%
SCM
3
Sandler Capital Management
New York
$10.4M -$4.5M -240,000 -28%
Vanguard Group
4
Vanguard Group
Pennsylvania
$10.4M -$50.7K -2,701 -0.4%
Russell Investments Group
5
Russell Investments Group
United Kingdom
$9.69M +$5.32M +283,603 +95%
BlackRock
6
BlackRock
New York
$9.19M +$210K +11,164 +2%
Ameriprise
7
Ameriprise
Minnesota
$9.12M +$6.29M +335,403 +158%
DCM
8
Driehaus Capital Management
Illinois
$8.34M +$670K +35,687 +8%
RIM
9
Ranger Investment Management
Texas
$5.12M +$1.26M +66,960 +28%
GIM
10
Granahan Investment Management
Massachusetts
$4.49M +$2.69M +143,595 +114%
GC
11
GMT Capital
Georgia
$4.26M +$4.8M +256,007 New
EIM
12
Essex Investment Management
Massachusetts
$3.36M -$428K -22,784 -10%
RA
13
Royce & Associates
New York
$3.27M +$188K +10,000 +5%
CCM
14
Cadence Capital Management
Massachusetts
$3.06M -$87.4K -4,659 -2%
PNC Financial Services Group
15
PNC Financial Services Group
Pennsylvania
$2.5M +$2.71M +144,150 +2,403%
Fidelity Investments
16
Fidelity Investments
Massachusetts
$2.49M
TAM
17
THB Asset Management
Connecticut
$2.44M +$2.76M +146,995 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$2.25M +$40.1K +2,138 +2%
State Street
19
State Street
Massachusetts
$2.17M +$335K +17,861 +16%
Wellington Management Group
20
Wellington Management Group
Massachusetts
$2.13M +$2.41M +128,200 New
PCM
21
Perkins Capital Management
Minnesota
$1.85M +$1.1M +58,500 +111%
Northern Trust
22
Northern Trust
Illinois
$1.76M +$1.03M +55,144 +108%
Allianz Asset Management
23
Allianz Asset Management
Germany
$1.45M -$2.41M -128,288 -60%
SSA
24
Schonfeld Strategic Advisors
New York
$1.4M -$1.82M -96,900 -53%
RC
25
Roubaix Capital
Colorado
$1.32M -$762K -40,589 -34%

BLFS Hedge Fund Activity: Q3 2019 in Review

80 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q3 2019, worth a combined $170M — up 13% from $150M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BLFS positions and 4 closed out — a net gain of 8 holders — while 28 added to existing stakes and 21 trimmed.

The largest buyer was Park West Asset Management, adding an estimated $8.36M. The largest seller was Sandler Capital Management, cutting an estimated $4.5M.

  • 80 institutional investors held BioLife Solutions (BLFS) as of Q3 2019, up from 73 in Q2 2019.
  • Funds reported $170M of BioLife Solutions stock for Q3 2019, up 13% quarter-over-quarter.
  • 12 funds opened new BioLife Solutions positions in Q3 2019 and 4 closed out, a net change of +8 holders.
  • The largest BioLife Solutions buyer in Q3 2019 was Park West Asset Management, an estimated $8.36M added.
  • The largest BioLife Solutions seller in Q3 2019 was Sandler Capital Management, an estimated $4.5M sold.

Based on aggregated 13F filings for Q3 2019.